Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 1
1967 1
1969 2
1973 1
1975 1
1976 3
1978 3
1979 2
1980 3
1981 2
1982 3
1983 4
1984 3
1985 2
1986 2
1987 4
1988 4
1989 9
1990 10
1991 7
1992 22
1993 14
1994 25
1995 14
1996 26
1997 11
1998 18
1999 16
2000 27
2001 23
2002 22
2003 16
2004 19
2005 20
2006 17
2007 26
2008 18
2009 25
2010 18
2011 24
2012 31
2013 35
2014 31
2015 37
2016 44
2017 32
2018 52
2019 39
2020 37
2021 38
2022 49
2023 26
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

842 results

Results by year

Filters applied: . Clear all
Page 1
Large-vessel vasculitis.
Pugh D, Karabayas M, Basu N, Cid MC, Goel R, Goodyear CS, Grayson PC, McAdoo SP, Mason JC, Owen C, Weyand CM, Youngstein T, Dhaun N. Pugh D, et al. Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5. Nat Rev Dis Primers. 2022. PMID: 34992251 Free PMC article. Review.
Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches and is the most common primary vasculitis in adults. LVV comprises two distinct conditions, giant cell arteritis and Takayasu arteritis, although the phenotypic spectr …
Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches and is the most common primary vasculitis in adu …
Takayasu arteritis.
Esatoglu SN, Hatemi G. Esatoglu SN, et al. Curr Opin Rheumatol. 2022 Jan 1;34(1):18-24. doi: 10.1097/BOR.0000000000000852. Curr Opin Rheumatol. 2022. PMID: 34698679 Review.
PURPOSE OF REVIEW: The purpose of this review is to summarize the recent advances in Takayasu arteritis (TAK), mainly focusing on pathogenesis, imaging modalities, and management. ...
PURPOSE OF REVIEW: The purpose of this review is to summarize the recent advances in Takayasu arteritis (TAK), mainly focusing …
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA. Hellmich B, et al. Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3. Ann Rheum Dis. 2020. PMID: 31270110
High dose glucocorticoid therapy (40-60 mg/day prednisone-equivalent) should be initiated immediately for induction of remission in active giant cell arteritis (GCA) or Takayasu arteritis (TAK). We recommend adjunctive therapy in selected patients with GCA (r …
High dose glucocorticoid therapy (40-60 mg/day prednisone-equivalent) should be initiated immediately for induction of remission in active g …
Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.
Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Watanabe R, et al. Curr Rheumatol Rep. 2020 Aug 26;22(10):68. doi: 10.1007/s11926-020-00948-x. Curr Rheumatol Rep. 2020. PMID: 32845392 Free PMC article. Review.
PURPOSE OF REVIEW: Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are auto-inflammatory and autoimmune diseases with a highly selective tissue tropism for medium and large arteries. ...
PURPOSE OF REVIEW: Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are auto-inflammatory and autoimmune disease …
Diagnostic and classification criteria of Takayasu arteritis.
de Souza AW, de Carvalho JF. de Souza AW, et al. J Autoimmun. 2014 Feb-Mar;48-49:79-83. doi: 10.1016/j.jaut.2014.01.012. Epub 2014 Jan 21. J Autoimmun. 2014. PMID: 24461381 Review.
Takayasu arteritis (TA) is a chronic large vessel vasculitis that affects aorta, its main branches and pulmonary arteries. ...
Takayasu arteritis (TA) is a chronic large vessel vasculitis that affects aorta, its main branches and pulmonary arteries. ...
Updates in the diagnosis and management of Takayasu's arteritis.
Somashekar A, Leung YT. Somashekar A, et al. Postgrad Med. 2023 Jan;135(sup1):14-21. doi: 10.1080/00325481.2022.2159723. Epub 2023 Jan 2. Postgrad Med. 2023. PMID: 36588528 Review.
Takayasu's arteritis is a rare, chronic, large vessel vasculitis which affects the aorta and its large branches. ...We also review the 2021 ACR guidelines for Takayasu's arteritis and correlate them to the updated evidence discussed throughout the revi …
Takayasu's arteritis is a rare, chronic, large vessel vasculitis which affects the aorta and its large branches. ...We also re …
Medium- and Large-Vessel Vasculitis.
Saadoun D, Vautier M, Cacoub P. Saadoun D, et al. Circulation. 2021 Jan 19;143(3):267-282. doi: 10.1161/CIRCULATIONAHA.120.046657. Epub 2021 Jan 19. Circulation. 2021. PMID: 33464968 Review.
The most common causes of large-vessel vasculitis are giant cell arteritis and Takayasu arteritis, and those of medium-vessel arteritis are polyarteritis nodosa and Kawasaki disease. ...
The most common causes of large-vessel vasculitis are giant cell arteritis and Takayasu arteritis, and those of medium- …
Takayasu arteritis: an update.
Keser G, Aksu K, Direskeneli H. Keser G, et al. Turk J Med Sci. 2018 Aug 16;48(4):681-697. doi: 10.3906/sag-1804-136. Turk J Med Sci. 2018. PMID: 30114347 Free article. Review.
Takayasu arteritis (TAK) is a challenging chronic, granulomatous, large-vessel systemic vasculitis, mostly due to difficulties in early diagnosis and assessing actual disease activity. ...Therefore, physical examination and new imaging findings should also be used t …
Takayasu arteritis (TAK) is a challenging chronic, granulomatous, large-vessel systemic vasculitis, mostly due to difficulties …
Vasculitis therapy refines vasculitis mechanistic classification.
Torp CK, Brüner M, Keller KK, Brouwer E, Hauge EM, McGonagle D, Kragstrup TW. Torp CK, et al. Autoimmun Rev. 2021 Jun;20(6):102829. doi: 10.1016/j.autrev.2021.102829. Epub 2021 Apr 16. Autoimmun Rev. 2021. PMID: 33872767 Free article. Review.
Studies on tumor necrosis factor alpha inhibition (adalimumab, infliximab, and etanercept) showed negative results in giant cell arteritis but some effect in Takayasu arteritis. Taken together, clinical studies with cytokine and cell specific drugs are dissec …
Studies on tumor necrosis factor alpha inhibition (adalimumab, infliximab, and etanercept) showed negative results in giant cell arteriti …
Takayasu arteritis: advanced understanding is leading to new horizons.
Tombetti E, Mason JC. Tombetti E, et al. Rheumatology (Oxford). 2019 Feb 1;58(2):206-219. doi: 10.1093/rheumatology/key040. Rheumatology (Oxford). 2019. PMID: 29635396 Free article. Review.
Although outcomes in Takayasu arteritis (TAK) are improving, diagnosis is typically delayed and significant arterial injury accrues. ...
Although outcomes in Takayasu arteritis (TAK) are improving, diagnosis is typically delayed and significant arterial injury ac …
842 results